The Tiger Dashboard – June 2026
“Most of the our industry is reading yesterday’s news. You’re about to read where Ortho is going.” I’m sharing the […]
“Most of the our industry is reading yesterday’s news. You’re about to read where Ortho is going.” I’m sharing the […]
It’s been a rough few years for orthopedic innovators needed capital. My short summary of the capital allocators during this
If you’ve been in the orthopedics game long enough, you remember the Golden Era. Thirty years ago, being an ortho
What this article will teach you. Reimbursement isn’t a math problem; it’s a structural maze. Stop building your commercial strategy
You are looking at your offer letter from an early-stage orthopedic company. You can understand the base salary, the bonus
For decades, the sports medicine market has been defined by the same frustrating tradeoffs: mechanical weaknesses in repair setups, clunky
Most of the industry is reading silly press releases, but here is your 7-day market update. The shift continues. Ortho
We all know that surgical site infections (SSIs) are the ultimate nightmare in orthopedics. A flawlessly executed procedure can be
For decades, the global orthopedic community has looked to the usual suspects for groundbreaking innovation: Warsaw, Indiana; Memphis, Tennessee; or
Joining a new orthopedic company is an exciting career move, but the medical device world carries unique financial risks. Long
Johnson & Johnson will sell or spinout its $20B DePuy Synthes orthopedics business, and that tell-all number tells you absolutely
Every Monday I share a startup that I really. I call it the Red-Hot Innovator of the Week. I am
Most of the industry is reading silly press releases, but here is your 7-day unredacted market update. The mega-trend in
We all know that orthopedics lags other medical areas in real-time patient data collection. But that’s about to change. The
Your people are your company. Not your product pipeline, your regulatory clearances, your facility, or your capital. Your people. They
In ortho sales, we are told that people are divided into two groups: “hunters” who chase new business and “gatherers”
Every Monday I share a startup that I really. I call it the Red-Hot Innovator of the Week. For decades,
Sharing a summary of orthopedic content that I consumed this week including some of the minor stories that you may
The capture of the US healthcare system has created a devastating reality: insurance giants, pharmaceutical benefit managers (PBMs), and a
In the orthopedic sales, not all revenue is created equal. When strategic buyers look at an orthopedic startup or mid-tier
The holy grail of orthopedic medicine is remarkably simple: getting a patient back to work and life, pain-free, as quickly
Every Monday I share a startup that I really like. I call it the Red-Hot Innovator of the Week. For
Startups are like very difficult uncharted journeys. Imagine a grueling expedition into uncharted territory. You have two distinct figures standing
The Class III pathway in orthopedics brutally slow, opaque, and unpredictable. If you ask the industry, we point to the
Why Read? This article explores a proven “ASC-only” strategy via an 8-step playbook for entrepreneurs, covering ASC-optimized product design, partnerships,
The lure of hiring a seasoned executive from a “Big Ortho” powerhouse—like Stryker, ZB, S+N, or DePuy—is a trap that
This is an attempt to explain the MiRus pivot to my ortho/spine readers. It’s hard to get your head around
Ortho Companies die in two ways: acute failure or chronic decay. Heart attack or cancer. 1/ A Heart Attack is
If you’ve spent any time reading OrthoStreams, you know my core philosophy: Business Model > Product. When I first wrote
I wrote about the psychologic dangers of Too Much Money ! on OrthoStreams in 2019. Today I need to explain
For decades, the orthopedic logistics world has treated field inventory like a necessary evil: flood the market with expensive metal,
In an orthopedic startups, talent isn’t just an asset—it’s your ultimate commercial engine. Every hire either accelerates your time-to-market or
If you have been keeping your ear to the ground in the spine world, you already know that spine endoscopy
How can a company with a truly great product turn into a zombie public company on life support? Today I
Let’s talk about the importance of two-way doors versus one-way doors. A one-way door decision is nearly impossible to reverse
I try to follow trends in ortho. Some reimbursement trends, like this one, pop up out of nowhere. Reimbursement pressure
Recently I have been helping ortho startups fix their hiring mistakes. This got me to thinking. Why do startup leaders
In the high-velocity ASCs, the single-use instrument kit has become the “easy button” for throughput. By sidestepping the logistical nightmare
For decades, the narrative in spine has been dominated by the giants—big companies with deep pockets running roughshod over the
The image of a surgical robot “chained” to the OR floor serves as a perfect metaphor for the current state
Your career in orthopedics isn’t a ladder; it’s a lifecycle, and most professionals are unknowingly trapped in a stage they
The statistics are brutal: 95% of spine startups fail. Usually, it’s not because the technology is bad, but because the “Valley of
“Most of the ortho industry is reading yesterday’s news. You’re about to get next month’s edge.” I’m sharing the new
I try to explore the truth here. Consistently I try to expose the false promise of most large robotics systems.
The results from our reader poll yesterday are in, and the verdict is clear: Choice #5—the tension between “Big-Box” Robotics
I want your opinion. There is a ton of change happening right now in ortho. Take a look at these
Small Ortho companies have NO EXCUSES any longer. For Small Ortho, the “low-hanging fruit” lies in AI tools that reduce
Startup founders often ask me about how to best fund their new venture. There is no single answer. Every company
I have previously written about the birthplace of modern ortho in Warsaw, or Why Warsaw? here. Today, let’s dive into
The orthopedic industry is currently undergoing a violent but necessary cleansing. We have officially exited the “FOMO” era of easy